• OrganiGram posted Q3 fiscal 2026 net revenue of CAD 105.78 million, up 49%, driven mainly by medical sales from the Sanity Group acquisition.
• Revenue mix: recreational CAD 61.82 million, medical CAD 39.03 million, wholesale and other CAD 4.93 million.
• Gross margin before fair value adjustments rose to CAD 38.8 million from CAD 22.42 million; margin expanded to 37% from 32% on Sanity contribution, domestic efficiencies.
• Adjusted EBITDA increased to CAD 13.41 million from CAD 5.69 million, reflecting higher gross margin and the addition of Sanity operations.
• Net income was CAD 105.54 million versus a loss of CAD 6.29 million, largely due to a CAD 105.78 million gain on fair value remeasurement of Preferred Shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrganiGram Global Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-055496), on August 11, 2026, and is solely responsible for the information contained therein.